{"id":26282,"date":"2019-06-28T16:20:00","date_gmt":"2019-06-28T20:20:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/blog\/junio-2019\/shirley"},"modified":"2022-10-14T18:56:23","modified_gmt":"2022-10-14T22:56:23","slug":"shirley","status":"publish","type":"post","link":"https:\/\/www.cancerresearch.org\/es\/blog\/shirley","title":{"rendered":"Shirley Dumont&#8217;s Immunotherapy Story"},"content":{"rendered":"\n<p><strong>C\u00e1ncer de vejiga | 2008<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Mi m\u00e9dico me dice la \u00abmujer bi\u00f3nica\u00bb. Todo es gracias a la inmunoterapia.<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">La historia de Shirley<\/h2>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Starting a New Day After Multiple Cancers: Shirley&#039;s Immunotherapy Story\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/xPwCYK2VOm4?list=PLiGDIj2dVt-h_Z6ehVsa4epspCI_-jqJr\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>Shirley Dumont tuvo c\u00e1ncer m\u00e1s veces de las que puede contar. Su historia comenz\u00f3 a los 39 a\u00f1os, cuando le diagnosticaron c\u00e1ncer de mama por primera vez. Despu\u00e9s de una mastectom\u00eda con quimioterapia, Shirley mantuvo un buen estado de salud hasta un poco antes de llegar a los 70 a\u00f1os, cuando sus m\u00e9dicos le encontraron\u00a0<a href=\"https:\/\/www.cancerresearch.org\/es\/cancer-types\/ovarian-cancer\">c\u00e1ncer de ovario<\/a>. Shirley se someti\u00f3 a una segunda mastectom\u00eda y le extirparon un ri\u00f1\u00f3n. Solo unos meses despu\u00e9s, tambi\u00e9n le detectaron\u00a0<a href=\"https:\/\/www.cancerresearch.org\/es\/cancer-types\/bladder-cancer\">c\u00e1ncer de vejiga<\/a>.\u00a0El c\u00e1ncer de vejiga se disemin\u00f3 r\u00e1pidamente por otros \u00f3rganos y le dijeron que solo le quedaban de 6 a 8 meses de vida.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Esperanzas de los ensayos cl\u00ednicos de inmunoterapia<\/h3>\n\n\n\n<p>En ese momento no exist\u00edan opciones de tratamiento corrientes para el c\u00e1ncer de vejiga metast\u00e1sico que no hab\u00eda respondido a la quimioterapia. Sin embargo, el Instituto oncol\u00f3gico Karmanos de Detroit llev\u00f3 a cabo un ensayo cl\u00ednico de\u00a0<a href=\"https:\/\/www.cancerresearch.org\/what-is-immunotherapy\">inmunoterapia<\/a>, un tipo de tratamiento contra el c\u00e1ncer que refuerza la capacidad del sistema inmunitario para combatir el c\u00e1ncer. Este ensayo cl\u00ednico probaba el atezolizumab (Tecentriq\u00ae), un inhibidor de puntos de control inmunitario PD-1.<\/p>\n\n\n\n<p>Judy, una amiga muy cercana de Shirley, nunca hab\u00eda o\u00eddo hablar de nadie que participara en un tratamiento como este contra el c\u00e1ncer, pero la alent\u00f3 a averiguar m\u00e1s sobre el estudio.. Con el apoyo de Judy y el resto de su familia, Shirley accedi\u00f3 a participar en el ensayo cl\u00ednico de inmunoterapia con la esperanza de que al menos, con su participaci\u00f3n, pudiera ayudar a otros. Le realizaron una exploraci\u00f3n por TAC despu\u00e9s de los primeros tres\u00a0tratamientos de inmunoterapia, y cuando su onc\u00f3loga, la Dra. Ulka Vaishampayan, entr\u00f3 al consultorio con los resultados de la prueba estaba sonriendo. Ah\u00ed fue cuando supieron que se renovaban las esperanzas de que Shirley se recuperara.<\/p>\n\n\n\n<p>No solo se desaceler\u00f3 el crecimiento del c\u00e1ncer de Shirley, sino que tambi\u00e9n respondi\u00f3 a la inmunoterapia con \u00abexcelentes resultados\u00bb, dijo la Dra. Vaishampayan. Los dem\u00e1s m\u00e9dicos de Shirley, que no cre\u00edan que pudiera sobrevivir a la enfermedad, la llaman la \u00abmujer bi\u00f3nica\u00bb. La Dra. Vaishampayan siente que, por primera vez, la inmunoterapia ofrece algo parecido a la cura para los tumores s\u00f3lidos metast\u00e1sicos de varios tipos de c\u00e1ncer. Solo es posible lograr nuevos avances con m\u00e1s ensayos cl\u00ednicos y buscando inspiraci\u00f3n en los buenos resultados de la inmunoterapia, como fue el caso de Shirley. El atezolizumab (Tecentriq\u00ae) est\u00e1 ahora aprobado por la FDA para el c\u00e1ncer de vejiga avanzado y como tratamiento de primera l\u00ednea para pacientes que no pueden recibir quimioterapia con cisplatino.<\/p>\n\n\n\n<p>Shirley y Judy apoyan al Cancer Research Institute en los esfuerzos por generar conciencia de las esperanzas y el potencial que ofrece la inmunoterapia. Consideran que deber\u00eda haber m\u00e1s ensayos de inmunoterapia para diferentes tipos de c\u00e1ncer, y creen en el decisivo papel que desempe\u00f1a la investigaci\u00f3n de la inmunoterapia para el futuro del tratamiento del c\u00e1ncer.<\/p>\n\n\n\n<p><strong>PUESTA AL D\u00cdA:&nbsp;<\/strong>Shirley falleci\u00f3 el&nbsp;23 de octubre de 2016. La inmunoterapia prolong\u00f3 su vida y le dio varios a\u00f1os m\u00e1s de actividad y felicidad junto a su familia.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Preguntas y respuestas<\/h2>\n\n\n\n\n<p>He tenido muchos tipos de c\u00e1ncer. La primera vez que me diagnosticaron ten\u00eda 39 a\u00f1os. Tuve c\u00e1ncer de mama, que lo trataron con una mastectom\u00eda y quimioterapia. Estuve bastante bien hasta hace 7 u 8 a\u00f1os, cuando encontraron c\u00e1ncer de ovario. Me hicieron una segunda mastectom\u00eda y me extirparon un ri\u00f1\u00f3n. Unos meses despu\u00e9s, encontraron c\u00e1ncer de vejiga.<\/p>\n\n\n\n\n\n<p>Cuando el c\u00e1ncer de vejiga dej\u00f3 de responder a la quimioterapia me qued\u00e9 sin opciones, salvo este ensayo cl\u00ednico. Mi amiga Judy nunca hab\u00eda conocido a nadie que participara en un estudio como este, pero dijo: \u00abVayamos, escuchemos lo que nos digan, lo que esperan de esto, y qu\u00e9 debes hacer para entrar en el estudio\u00bb. Mi hijo, que estaba detr\u00e1s de m\u00ed, me dec\u00eda: \u00abMam\u00e1, tienes que intentar todo\u00bb. As\u00ed que acept\u00e9 participar. Nunca hab\u00eda o\u00eddo hablar de la inmunoterapia, pero pens\u00e9: \u00abBueno, si esto puede ayudar a otras personas, \u00a1genial!\u00bb<\/p>\n\n\n\n\n\n<p>Nunca volver\u00eda a someterme a quimioterapia, ya lo hice tres veces. Nunca m\u00e1s, porque la inmunoterapia es un juego de ni\u00f1os en comparaci\u00f3n con la quimioterapia tradicional. No se me ca\u00eda el pelo, segu\u00eda con energ\u00eda, cu\u00e1nta diferencia. \u00a1Mis amigos me dicen que ni siquiera parezco enferma!<\/p>\n\n\n\n\n\n<p>Necesitamos m\u00e1s estudios como este para diferentes tipos de c\u00e1ncer. Queremos hacer correr la voz a trav\u00e9s del Cancer Research Institute: La inmunoterapia es algo bueno. Es as\u00ed. Esperamos que haya m\u00e1s tratamientos de inmunoterapia y tal vez alg\u00fan d\u00eda se pueda erradicar el c\u00e1ncer por completo.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>C\u00e1ncer de vejiga | 2008 Mi m\u00e9dico me dice la \u00abmujer bi\u00f3nica\u00bb. Todo es gracias a la inmunoterapia. La historia de Shirley Shirley Dumont tuvo c\u00e1ncer m\u00e1s veces de las que puede [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":21885,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[678],"tags":[685,439],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-26282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-story-es","tag-bladder-cancer-es","tag-patient-stories-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shirley Dumont&#039;s Immunotherapy Story - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/blog\/shirley\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shirley Dumont&#039;s Immunotherapy Story - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"C\u00e1ncer de vejiga | 2008 Mi m\u00e9dico me dice la \u00abmujer bi\u00f3nica\u00bb. Todo es gracias a la inmunoterapia. La historia de Shirley Shirley Dumont tuvo c\u00e1ncer m\u00e1s veces de las que puede [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/blog\/shirley\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-28T20:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-14T22:56:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"551\" \/>\n\t<meta property=\"og:image:height\" content=\"551\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CRI Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"CRI Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley\"},\"author\":{\"name\":\"CRI Staff\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\"},\"headline\":\"Shirley Dumont&#8217;s Immunotherapy Story\",\"datePublished\":\"2019-06-28T20:20:00+00:00\",\"dateModified\":\"2022-10-14T22:56:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley\"},\"wordCount\":880,\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg\",\"keywords\":[\"bladder cancer\",\"patient stories\"],\"articleSection\":[\"Patient Story\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley\",\"url\":\"https:\/\/www.cancerresearch.org\/blog\/shirley\",\"name\":\"Shirley Dumont's Immunotherapy Story - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg\",\"datePublished\":\"2019-06-28T20:20:00+00:00\",\"dateModified\":\"2022-10-14T22:56:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/blog\/shirley\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg\",\"width\":551,\"height\":551,\"caption\":\"Shirley Dumont\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/shirley#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shirley Dumont&#8217;s Immunotherapy Story\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\",\"name\":\"CRI Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"caption\":\"CRI Staff\"},\"url\":\"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shirley Dumont's Immunotherapy Story - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/blog\/shirley","og_locale":"es_ES","og_type":"article","og_title":"Shirley Dumont's Immunotherapy Story - Cancer Research Institute","og_description":"C\u00e1ncer de vejiga | 2008 Mi m\u00e9dico me dice la \u00abmujer bi\u00f3nica\u00bb. Todo es gracias a la inmunoterapia. La historia de Shirley Shirley Dumont tuvo c\u00e1ncer m\u00e1s veces de las que puede [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/blog\/shirley","og_site_name":"Cancer Research Institute","article_published_time":"2019-06-28T20:20:00+00:00","article_modified_time":"2022-10-14T22:56:23+00:00","og_image":[{"width":551,"height":551,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg","type":"image\/jpeg"}],"author":"CRI Staff","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"CRI Staff","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#article","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley"},"author":{"name":"CRI Staff","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4"},"headline":"Shirley Dumont&#8217;s Immunotherapy Story","datePublished":"2019-06-28T20:20:00+00:00","dateModified":"2022-10-14T22:56:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley"},"wordCount":880,"publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg","keywords":["bladder cancer","patient stories"],"articleSection":["Patient Story"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/blog\/shirley","url":"https:\/\/www.cancerresearch.org\/blog\/shirley","name":"Shirley Dumont's Immunotherapy Story - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg","datePublished":"2019-06-28T20:20:00+00:00","dateModified":"2022-10-14T22:56:23+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/blog\/shirley"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/shirley-551_v2.jpg","width":551,"height":551,"caption":"Shirley Dumont"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/blog\/shirley#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Shirley Dumont&#8217;s Immunotherapy Story"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4","name":"CRI Staff","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","caption":"CRI Staff"},"url":"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff"}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/comments?post=26282"}],"version-history":[{"count":0,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26282\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/21885"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=26282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/categories?post=26282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=26282"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=26282"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=26282"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=26282"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=26282"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=26282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}